176 related articles for article (PubMed ID: 10392016)
1. [Bone marrow allograft. Part 1: principles--modalities and indications].
Ladeb S; Abdelkefi A; Ben Othman T; Torjmene L; Ben Abdeladhim A
Tunis Med; 1999 Apr; 77(4):185-90. PubMed ID: 10392016
[No Abstract] [Full Text] [Related]
2. [Bone marrow transplantation from non-consanguineous compatible donors: current state and prospects].
Bacigalupo A
Haematologica; 1991 Jun; 76 Suppl 3():34-9. PubMed ID: 1752529
[No Abstract] [Full Text] [Related]
3. [Technology of bone marrow transplantation--harvest and manipulation of bone marrow cells].
Shinohara Y
Nihon Rinsho; 1990 Sep; 48(9):2023-7. PubMed ID: 2232206
[No Abstract] [Full Text] [Related]
4. Second donation of bone marrow: results from the Japan Marrow Donor Program (JMDP).
Akiyama H; Hara M; Hino M; Sao H; Hoshi Y; Ohto H; Kai S
Bone Marrow Transplant; 2006 Apr; 37(8):795-6. PubMed ID: 16518426
[No Abstract] [Full Text] [Related]
5. [Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].
Remes K; Luoma S; Salmi TT; Tarja-Terttu P; Itälä M; Kauppila M; Nikoskelainen J; Putkonen M; Kairisto V; Rajamäki A; Tienhaara A; Pyrhönen S; Rauhala A
Duodecim; 2005; 121(19):2085-97. PubMed ID: 16300297
[No Abstract] [Full Text] [Related]
6. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
[TBL] [Abstract][Full Text] [Related]
7. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency.
Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H
Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359
[No Abstract] [Full Text] [Related]
8. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients.
Bertrand Y; Müller SM; Casanova JL; Morgan G; Fischer A; Friedrich W
Bone Marrow Transplant; 2002 May; 29(9):759-62. PubMed ID: 12040473
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation from HLA-matched unrelated donors as treatment for leukemia.
Champlin R
J Hematother; 1993; 2(3):323-7. PubMed ID: 7921993
[No Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation in Fanconi anemia.
Gluckman E
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S33-5. PubMed ID: 8971405
[No Abstract] [Full Text] [Related]
11. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
13. The Czech National Register of bone marrow donors.
Ivasková E; Ivanyi P
Folia Biol (Praha); 1994; 40(6):395-9. PubMed ID: 7589698
[No Abstract] [Full Text] [Related]
14. Donor selection-matching for mismatches.
Pay AL; Perez-Rodriguez M; Madrigal JA
Haematologica; 1999 Jun; 84 Suppl EHA-4():44-5. PubMed ID: 10907465
[No Abstract] [Full Text] [Related]
15. [Allogeneic bone marrow transplantation].
Sengeløv H; Nielsen B; Vindeløv LL
Ugeskr Laeger; 2003 Dec; 165(50):4844-6. PubMed ID: 14716901
[No Abstract] [Full Text] [Related]
16. Allogeneic bone marrow transplantation in a child with severe aplastic anemia and hemophilia A.
Ostronoff M; Ostronoff F; Campos G; Arruda S; Vaz C; Florencio R; Calixto R; Souto Maior AP; Sucupira A; Domingues M; Tagliari C
Bone Marrow Transplant; 2006 Mar; 37(6):627-8. PubMed ID: 16444275
[No Abstract] [Full Text] [Related]
17. [Selection of bone marrow donors for allogeneic transplantation. General principles].
Wiktor-Jedrzejczak W
Acta Haematol Pol; 1987; 18(3-4):199-202. PubMed ID: 3330396
[No Abstract] [Full Text] [Related]
18. Bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world. The Executive Committee of the World Marrow Donor Association.
Bone Marrow Transplant; 1992 Sep; 10(3):287-91. PubMed ID: 1422482
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
20. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
